NEW YORK (GenomeWeb News) – Martin Madaus will take the CEO and chairman posts at Ortho Clinical Diagnostics upon the closure of The Carlyle Group's acquisition of OCD from Johnson and Johnson, which is expected to be mid-2014, OCD said this week.

Madaus recently was president, chairman, and CEO of Millipore, and is currently executive chairman of Quanterix's board of directors. He also is a director at Carlyle's portfolio companies PPD, Mettler Toledo, and Covidien.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.